| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/21/2006 | CA2599899A1 Fused thieno [2, 3-b] pyridine and thiazolo [5, 4-b] pyridine compounds for inhibiting ksp kinesin activity |
| 09/21/2006 | CA2599643A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/21/2006 | CA2599538A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 09/21/2006 | CA2599476A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 09/20/2006 | EP1702985A2 Preferred segments of neural thread protein and methods of using the same |
| 09/20/2006 | EP1702984A2 A method for detecting prostate cancer |
| 09/20/2006 | EP1702983A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof |
| 09/20/2006 | EP1702982A1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 09/20/2006 | EP1702928A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1702917A1 Amide derivative and medicine |
| 09/20/2006 | EP1702625A1 Medicine containing genetically modified antibody against chemokine receptor ccr4 |
| 09/20/2006 | EP1702624A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 09/20/2006 | EP1702618A2 Compositions and uses of ET743 in combination therapy for cancer treatment |
| 09/20/2006 | EP1702617A1 Cannabimimetic indole derivatives |
| 09/20/2006 | EP1702613A1 Preventive for the onset of liver cancer comprising quinone compound as the active ingredient |
| 09/20/2006 | EP1702069A2 Interleukin-12 targeted to oncofoetal fibronectin |
| 09/20/2006 | EP1701957A1 2-amino-o4-substituted pteridines and their use as inactivators of o6-alkylguanine-dna alkyltransferase |
| 09/20/2006 | EP1701953A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 09/20/2006 | EP1701939A1 Anthraquinone compounds as anti cancer compounds |
| 09/20/2006 | EP1701736A1 Therapeutic agents and uses therefor |
| 09/20/2006 | EP1701720A1 Use of chp as an inhibitor of glutathione s-transferases and collagen iv |
| 09/20/2006 | EP1701719A1 Chp-gemcitabin combined agent and use thereof as anti-tumoural active substances |
| 09/20/2006 | EP1554253A4 Imidazolium cxcr3 inhibitors |
| 09/20/2006 | EP1432792B1 Histone deacetylase 9 |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1276491B1 Tamandarin and didemnin analogs and methods of making and using them |
| 09/20/2006 | EP1272530B1 Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 09/20/2006 | EP1272188B1 Use of egfr tyrosine kinase inhibitors for treating brest cancer |
| 09/20/2006 | EP1246841B1 Transcription factors containing two potential dna binding motifs |
| 09/20/2006 | EP1156827B1 USE OF COMPOSITIONS COMPRISING CldC AS RADIOSENSITIZERS IN THE TREATMENT OF NEOPLASTIC DISEASES |
| 09/20/2006 | EP1079875B1 Cancer treatment by ultrapheresis removing compounds of less than 120,000 daltons |
| 09/20/2006 | EP1073648B1 12,13-modified epothilone derivatives |
| 09/20/2006 | EP0975361B1 Methods of modulating immune coagulation |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | CN1835969A Mechanism of conditional regulation of hypoxia-inducible factor-1 by von Hippel-Lindau tumor suppressor protein |
| 09/20/2006 | CN1835964A Target-oriented chemotherapy for treating tumors of the sexual organs |
| 09/20/2006 | CN1835962A Compositions and methods for treatment of disease with acetylated disaccharides |
| 09/20/2006 | CN1835952A Compounds and compositions as inhibitors of receptor tyrosine kinase activity |
| 09/20/2006 | CN1835951A Isethionate salt of a selective CDK4 inhibitor |
| 09/20/2006 | CN1835950A Imidazopyridine derivatives |
| 09/20/2006 | CN1835945A Chinazoline derivatives as aurora kinase inhibitors |
| 09/20/2006 | CN1835757A Compositions comprising ZD6126 together with 5-FU, CPT-11 or 5-FU and CPT-11 having vascular damaging activity for treating e.g. colorectal cancer |
| 09/20/2006 | CN1835756A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 09/20/2006 | CN1835749A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 09/20/2006 | CN1835748A Use of cyclopamine in the treatment of psoriasis and other skin disorders |
| 09/20/2006 | CN1835740A Pharmaceutical compositions and methods for the prevention of breast and ovarian cancer |
| 09/20/2006 | CN1834254A Carrier PCD-VEGF able to stable express VEGF shRNA |
| 09/20/2006 | CN1834244A Full length polynucleotide sequence of new allelic gene A*110104 of encoded human leucocyte antigen A*11 and uses thereof |
| 09/20/2006 | CN1834242A Use of artificial proliferative inhibiting gene-adenovirus expression carrier |
| 09/20/2006 | CN1834108A Acanthopanax giraldii Harms compound polysaccharide, prepn. technique, uses and its compound polysaccharide compsns. |
| 09/20/2006 | CN1834088A Tetrapeptide derivative crystals |
| 09/20/2006 | CN1833724A Cancer treatment through suction effect T-cell and loss regulating T-cell |
| 09/20/2006 | CN1833721A Compsns. of thymopentin and interferon |
| 09/20/2006 | CN1833720A Biological answer-reply regulator of microbe extracting factor |
| 09/20/2006 | CN1833717A Method of preparing cantharides capsule |
| 09/20/2006 | CN1833697A Expelling toxin opsonic water, opsonic pills and prepn. method thereof |
| 09/20/2006 | CN1833681A 'Senwei' anti-cancer capsules and its prepn. process |
| 09/20/2006 | CN1833671A Paste for relieving mammary gland gall |
| 09/20/2006 | CN1833667A Natural indigo ketone oral liquor or injection and usage |
| 09/20/2006 | CN1833636A Application of biphenyl cyclooctadiene lignin in treatment of tumour medicine |
| 09/20/2006 | CN1276549C Apparatus for a quick release safety connector assembly |
| 09/20/2006 | CN1276083C Altering gene expression with ssDNA produced in vivo |
| 09/20/2006 | CN1275978C Oslasodine hydrochloride preparing process |
| 09/20/2006 | CN1275966C Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for prodn. thereof and pharmaceutical compsns. contg. said derivatives |
| 09/20/2006 | CN1275965C Derivatives of variolin b |
| 09/20/2006 | CN1275959C Pterocarya stenoptera extract, its preparation and use |
| 09/20/2006 | CN1275954C Hydroxamic acid derivatives |
| 09/20/2006 | CN1275923C Use of 2',4'-dihydroxy-6'-methoxy-3',5'-dimethyl chalkone as reversing agent for resistance of multiple tumours drugs |
| 09/20/2006 | CN1275648C Vaccin composition, preparation method and use thereof |
| 09/20/2006 | CN1275632C Medicated wine for treating intestinal cancer |
| 09/20/2006 | CN1275600C Vitamin-medicine composition and its use |
| 09/20/2006 | CN1275594C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/20/2006 | CN1275593C Dispersible tablet of tamoxifen citrate and preparation method thereof |
| 09/19/2006 | US7109364 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
| 09/19/2006 | US7109361 Isolation of lutein from alfalfa |
| 09/19/2006 | US7109342 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 09/19/2006 | US7109341 Antitumor agents; such as 2-(4-((7-Bromo-2-quinolinyl)oxy)phenoxy)propionmethylamide |
| 09/19/2006 | US7109340 Substituted tetrahydro-1H-pyrazolo [3,4-c] pyridines, compositions comprising them, and use |
| 09/19/2006 | US7109337 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/19/2006 | US7109335 5-[4-(3-Methanesulfonyl-benzylamino)-5-trifluoromethyl-pyrimidin-2-ylamino]-1,3-dihydro-indol-2-one; inhibitors of the FAK protein tyrosine kinases, antiproliferative, antitumor |
| 09/19/2006 | US7109333 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects |
| 09/19/2006 | US7109331 Antiprotozoa agents; 4-pyrrolidine pyrrolo(3,2-d)pyrimidine and 4-pyrrolidine pyrazolo(4,3-d)pyrimidine derivatives |
| 09/19/2006 | US7109330 {(2-hydroxyethyl)[9-(methylethyl)-6-(3-quinolylamino)purin-2-yl]amino}ethan-1-ol; antiproliferatives, treating rheumatoid arthritis, lupus, type I diabetes, multiple sclerosis, cancer, restenosis, host graft disease, and gout |
| 09/19/2006 | US7109323 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 09/19/2006 | US7109322 Process for the depletion or removal of endotoxins |
| 09/19/2006 | US7109303 Modified cytokines for use in cancer therapy |
| 09/19/2006 | US7109236 Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents |
| 09/19/2006 | US7109235 Microtubule stabilizing compounds |
| 09/19/2006 | US7109229 Methods and compounds for treating proliferative diseases |
| 09/19/2006 | US7109219 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 09/19/2006 | US7109218 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/19/2006 | US7109204 Tyrosine kinase inhibitors |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7109199 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 09/19/2006 | US7109196 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 09/19/2006 | US7109195 Hexacyclic compounds and their therapeutic use |
| 09/19/2006 | US7109194 3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use |
| 09/19/2006 | US7109191 for inhibiting bone resorption, restenosis, atherosclerosis, inflammatory arthritis, diabetic retinopathy, macular degeneration, angiogenesis, cancer |
| 09/19/2006 | US7109185 Pharmaceutical formulations comprising indolinone derivatives |